♦Altretamine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Altretamine

♦Altretamine (al-treh’-tah-meen) Hexalen Pregnancy Category D Mechanism of Action Unknown Indications ♦ Palliative treatment for recurrent or persistent ovarian cancer after first-line therapy with cisplatin or alkylating agent; use as…

read more

♦Aldesleukin

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Aldesleukin

♦Aldesleukin (al-des-loo’-ken) Proleukin, interleukin-2 Pregnancy Category C Mechanism of Action Inhibits tumor growth; exerts immunologic effects by activating the cellular immunity to increase lymphocytes, eosinophils, platelets, and cytokines, including tumor…

read more

FDA Pregnancy Categories

Jul 20, 2016 by in ONCOLOGY Comments Off on FDA Pregnancy Categories

FDA Pregnancy Categories The Food and Drug Administration has established five categories to indicate the potential for a systemically absorbed drug to cause birth defects. The key differentiation among the…

read more

Patient Education

Jul 20, 2016 by in ONCOLOGY Comments Off on Patient Education

Patient Education Patient education is an important component of care. An increasing number of cancer patients are undergoing multiple treatment modalities, and they need knowledge and skills to cope with…

read more

Management of Toxic Effects of Chemotherapy

Jul 20, 2016 by in ONCOLOGY Comments Off on Management of Toxic Effects of Chemotherapy

Management of Toxic Effects of Chemotherapy Chemotherapy, like any medication, has the potential to cause side effects. Unique to these agents, however, are the nature and extent of the injury…

read more

Management of Hypersensitivity Reactions and Extravasation

Jul 20, 2016 by in ONCOLOGY Comments Off on Management of Hypersensitivity Reactions and Extravasation

Management of Hypersensitivity Reactions and Extravasation Hypersensitivity Reactions Hypersensitivity reactions (HSRs) are common in patients receiving chemotherapy. These reactions, which may be local or systemic, are believed to be immunologically…

read more

Preparation, Administration, and Handling of Chemotherapy

Jul 20, 2016 by in ONCOLOGY Comments Off on Preparation, Administration, and Handling of Chemotherapy

Preparation, Administration, and Handling of Chemotherapy Ensuring Patient Safety: Preventing Chemotherapy Errors The chemotherapy administration process provides many opportunities for various health care professionals to make mistakes. The error may…

read more

Clinical Trials

Jul 20, 2016 by in ONCOLOGY Comments Off on Clinical Trials

Clinical Trials The goals of clinical cancer research are to improve the therapeutic outcomes for cancer patients and to improve the quality of care. Important progress in cancer therapy has…

read more

Biologic Response Modifiers

Jul 20, 2016 by in ONCOLOGY Comments Off on Biologic Response Modifiers

Biologic Response Modifiers Janet Gordils-Perez Biologic therapy is the fourth modality in the treatment of cancer, after surgery, chemotherapy, and radiation. Biologic therapy produces anticancer effects either through the actions…

read more

Overview of Chemotherapy

Jul 20, 2016 by in ONCOLOGY Comments Off on Overview of Chemotherapy

Overview of Chemotherapy Chemotherapy is the use of cytotoxic agents to destroy cancer cells. Chemotherapy dates back to the 1500s, when heavy metals were used systemically to treat cancers, and…

read more
Get Clinical Tree app for offline access